αβ and γδ T-cell networks and their roles in natural resistance to viral infections

Immunological Reviews

Volumn 159, Issue , 1997, Pages 79-93

  Welsh, Raymond M ^a   Lin, Meei Yun ^a   Lohman, Barbara L ^a   Varga, Steven M ^a   Zarozinski, Christopher C ^a   Selin, Liisa K ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD8 ANTIGEN; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; T LYMPHOCYTE RECEPTOR DELTA CHAIN; T LYMPHOCYTE RECEPTOR GAMMA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CYTOTOXIC T LYMPHOCYTE; HUMAN; IMMUNE DEFICIENCY; IMMUNOMODULATION; IMMUNOPATHOLOGY; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MEMORY CELL; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOBLAST; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VACCINIA VIRUS; VIRUS IMMUNITY; VIRUS INFECTION; VIRUS RESISTANCE;

EID: 0030670976     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065x.1997.tb01008.x     Document Type: Review

References (83)

1. Bukowski JF, Warner JR, Dennert G, Welsh RM. Adoptive transfer studies demonstrating the antiviral effect of natural killer cells in vivo. J Exp Med 1985;161:40-52.
2. Orange JS, Wang B, Terhorst C, Biron CA. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 1995;182:1045-1056.
3. Tay CH, Welsh RM. Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 1997;71:267-275.
4. Vargas-Cortes M, O'Donnell CL, Maciaszek JW, Welsh RM. Generation of "natural killer-escape" variants of Pichinde virus during acute and persistent infections. J Virol 1992;66:2532-2535.
5. Karupiah G, Blanden RV, Ramshaw IA. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J Exp Med 1990;172:1495-1503.
6. Bukowski JF, McIntyre KW, Yang H, Welsh RM. Natural killer cells are not required for interferon-mediated prophylaxis against vaccinia or murine cytomegalovirus infections. J Gen Virol 1987;68:2219-2222.
7. Delano ML, Brownstein DG. Innate resistance to lethal mousepox is genetically linked to the NK gene complex on chromosome 6 and correlates with early restriction on virus replication by cells with an NK phenotype. J Virol 1995;69:5875-5877.
8. Rager-Zisman B, Quan P-C, Rosner M, Moller JR, Bloom BR. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J Immunol 1997;138:884-888.
9. + T cells. J Exp Med 1990;172:1225-1231.
10. Bukowski JF, Morita CT, Brenner M. Recognition and destruction of virus-infected cells by human γδ CTL. J Immunol 1994;154:5133-5140.
11. - T cell receptor-γδ T lymphocyte clone specific for herpes simplex virus glycoprotein I. J Immunol 1992;148:983-988.
12. Sciammas R, Kodukula P, Tang Q, Hendricks RL, Bluestone JA. T cell receptor-γ/δ cells protect mice from herpes simplex virus type 1-induced lethal encephalitis. J Exp Med 1997;185:1969-1976.
13. Mombaerts P, et al. Mutations in T-cell antigen receptor genes α and β block thymocyte development at different stages. Nature 1997;360:225-231.
14. Doherty PC, Zinkernagel RM. T-cell-mediated immunopathology in viral infections. Transplant Rev 1974;19:89-120.
15. Cole GA, Nathanson N, Prendergast RA. Requirement for Φ-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature 1972;238:335-337.
16. Zinkernagel RM, Doherty PC. H-2 compatibility requirement for T cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T cell specificities are associated with structures coded for in H-2K or H-2D. J Exp Med 1975;141:1427-1436.
17. Zinkernagel RM, Welsh RM. H-2 compatibility requirement for virus-specific T cell-mediated effector functions in vivo. I. Specificity of T cells conferring antiviral protection against lymphocytic choriomeningitis virus is associated with H-2K and H-2D. J Immunol 1976;117:1495-1502.
18. Whitton JL, Gebhard JR, Lewicki H, Tishon A, Oldstone MBA. Molecular definition of a major cytotoxic T-lymphocyte epitope in the glycoprotein of lymphocytic choriomeningitis virus. J Virol 1988;62:687-695.
19. Whitton JL, et al. Molecular analyses of a five-amino-acid cytotoxic T-lymphocyte (CTL) epitope: an immunodominant region which induces nonreciprocal CTL cross-reactivity. J Virol 1989;63:4303-4310.
20. Whitton JL, Southern PJ, Oldstone MBA. Analyses of the cytotoxic T lymphocyte responses to glycoprotein and nucleoprotein components of lymphocytic choriomeningitis virus. Virology 1988;162:321-327.
21. + T cells based on α4 integrin expression. Int Immunol 1996;8:707-715.
22. McFarland HI, Nahill SR, Maciaszek JW, Welsh RM. CD11b (Mac-1): a marker for CD8+ cytotoxic T cell activation and memory in virus infection. J Immunol 1992;149:1326-1333.
23. Townsend ARM, Rothband J, Gotch F, Bahadur G, Wraith DC, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986;44:959-968.
24. Andersson EC, Christenson JP, Marker O, Thomsen AR. Changes in cell adhesion molecule expression on T cells associated with systemic virus infection. J Immunol 1994;152:1237-1245.
25. + memory T cells in virus-infected hosts. J Exp Med 1996;183:1367-1375.
26. + memory T cells. J Immunol 1995;154:5870-5875.
27. Biron CA, Natuk RJ, Welsh RM. Generation of large granular T lymphocytes in vivo during viral infection. J Immunol 1986;136:2280-2286.
28. Lau LL, Jamieson BD, Somasundaram T, Ahmed R. Cytotoxic T-cell memory without antigen. Nature 1994;369:648-652.
29. Selin LK, Vergilis K, Welsh RM, Nahill SR. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J Exp Med 1996;183:2489-2499.
30. Tough DF, Sprent J. Turnover of naive- and memory-phenotype T cells. J Exp Med 1994;179:1127-1135.
31. Ehl S, Hombach J, Aichele P, Hengartner H, Zinkernagel RM. Bystander activation of cytotoxic T cells: studies on the mechanism and evaluation of in vivo significance in a transgenic mouse model. J Exp Med 1997;185:1241-1251.
32. Tough DL, Borrow P, Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon. Science 1996;272:1947-1950.
33. + thymocytes. Nature 1997;333:742-746.
34. Rocha B, von Boehmer H. Peripheral selection of the T cell repertoire. Science 1991;251:1225-1228.
35. Zarozinski CC, Welsh RM. Minimal bystander activation of CD8 T cells during the virus-induced polyclonal T cell response. J Exp Med 1997;185:1629-1639.
36. Yang H, Dundon PL, Nahill SR, Welsh RM. Virus induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 1989;142:1710-1718.
37. Yang H, Welsh RM. Induction of alloreactive cytotoxic T cells by acute virus infection. J Immunol 1986;136:1186-1193.
38. Nahill SR, Welsh RM. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response. J Exp Med 1993;177:317-327.
39. Selin LK, Nahill SR, Welsh RM. Cross-reactivities in memory cytotoxic T lymphocyte recognition of heterologous viruses. J Exp Med 1994;179:1933-1943.
40. Tomkinson BE, Maziarz R, Sullivan JL. Characterization of the T cell-mediated cellular cytotoxicity during infectious mononucleosis. J Immunol 1989;143:660-670.
41. Strang G, Rickinson AB. Multiple HLA Class I-dependent cytotoxicities constitute the 'non-HLA-restricted' response to infectious mononucleosis. Eur J Immunol 1987;17:1007-1014.
42. Tanchot C, Lemonnier FA, Perarnau B, Freitas AA, Rocha B. Differential requirements for survival and proliferation of CD8 naive or memory T cells. Science 1997;176:2057-2062.
43. von Pirquet C. Das verhalten der kutanen tuberkulin-reaktion wahrend der Masern. Dtsch Med Wochenschr 1908;34: 1297-1300.
44. Jacobs RP, Cole GA. Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J Immunol 1976;117:1004-1009.
45. Saron MF, Shidani B, Nahori MA, Guillon JC, Truffa-Bachi P. Lymphocytic choriomeningitis virus-induced immunodepression: inherent defect of B and T lymphocytes. J Virol 1990;64:4076-4083.
46. Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RPM, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992;257:217-219.
47. Razvi ES, Welsh RM. Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol 1993;67:5754-5765.
48. Groux HG, Torpier G, Monte D, Mouton Y, Capron A, Ameisen JC. Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals. J Exp Med 1992;175:331-340.
49. Green DR, Bissonnette RP, Glynn JM, Shi Y. Activation-induced apoptosis in lymphoid systems. Semin Immunol 1992;4:379-388.
50. Kawabe Y, Ochi A. Programmed cell death and extrathymic reduction of Vbeta8+CD4+T cells in mice tolerant to Staphylococcus aureus enterotoxin B. Nature 1991;349:245-248.
51. Russell JH, White CL, Loh DY, Meleedy-Rey P. Receptor-stimulated death pathway is opened by antigen in mature T cells. Proc Natl Acad Sci USA 1991;88:2151-2155.
52. Razvi ES, Jiang Z, Woda BA, Welsh RM. Lymphocyte apoptosis during the silencing of the immune response to acute viral infections in normal, lpr and Bcl-2-transgenic mice. Am J Pathol 1995;147:79-91.
53. Lohman BL, Razvi ES, Welsh RM. T-lymphocyte downregulation after acute viral infection is not dependent on CD95 (Fas) receptor-ligand interactions. J Virol 1996;70:8199-8203.
54. Moskophidis D, Lechner F, Pircher H, Zinkernagel RM. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells. Nature 1993;362:758-761.
55. Gavrieli Y, Sherman Y, Ben-Sasson S. Identification of programmed cell death in situ via specific labelling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
56. high γδ T cells in Lyme arthritis. J Exp Med 1996;184:2109-2117.
57. Biron CA. Cytokines in the generation of immune responses to, and resolution of, virus infection. Curr Opin Immunol 1994;6:530-538.
58. Pannetier C, Even J, Kourilsky P. T-cell repertoire diversity and clonal expansions in normal and clinical samples. Immunol Today 1995;16:176-181.
59. Bjorkman PJ. MHC restriction in three dimensions: a view of T cell receptor/ligand interactions. Cell 1997;89:167-170.
60. Razvi ES, Welsh RM, McFarland HI. In vivo state of antiviral CTL precursors: characterization of a cycling population containing CTL precursors in immune mice. J Immunol 1995;154:620-632.
61. Selin LK, Welsh RM. Cytolytically active memory CTL present in lymphocytic choriomeningitis virus-immune mice after clearance of virus infection. J Immunol 1997;158:5366-5373.
62. Tabi Z, Lynch F, Ceredig R, Allan JE, Doherty PC. Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol 1988;113:268-277.
63. Bradley LM, Croft M, Swain SL. T-cell memory: new perspectives. Immunol Today 1993;14:197-199.
64. Anderson RW, Bennick JR, Yewdell JW, Maloy WL, Coligan JE. Influenza basic polymerase 2 peptides are recognized by influenza nucleoprotein-specific cytotoxic T lymphocytes. Mol Immunol 1992;29:1089-1096.
65. d-restricted, influenza specific CTL clone. Mol Immunol 1991;28:1-7.
66. Shimojo N, Maloy WL, Anderson RW, Biddison WE, Coligan JE. Specificity of peptide binding by the HLA-A2.1 molecule. J Immunol 1989;143:2939-2947.
67. Welsh RM, Tay C, Varga SM, O'Donnell CL, Vergilis KL, Selin LK. Lymphocyte-dependent "natural" immunity to virus infections mediated by both natural killer cells and memory T cells. Semin Virol VI 1996;7:95-102.
68. Muller U, et al. Functional role of type I and type II interferons in antiviral defense. Science 1994;264:1918-1921.
69. Welsh RM, Sen GC. Non-specific host responses to viral infections. In: Nathanson N, ed. Viral pathogenesis. New York: Lippincott-Raven Publishers; 1996. p. 109-142.
70. Kapikian AZ, Mitchell RH, Chanock RM, Shvedoff RA, Stewart CE. An epidemiological study of altered clinical reactivity to respiratory syncitial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine. Am J Epidemiol 1969;89:405-421.
71. Rickinson AB, Kieff E. Epstein-Barr virus. In: Fields BN, et al. eds. Virology Volume 2. Philadelphia: Lippincott-Raven Publishers; 1996. p. 2397-2446.
72. Weinstein L, Meade RH. Respiratory manifestations of chickenpox. Arch Intern Med 1956;98:91-99.
73. Yang H, Joris I, Majno G, Welsh RM. Necrosis of adipose tissue induced by sequential infections with unrelated viruses. Am J Pathol 1985;120:173-177.
74. Fazekas de St Groth S, Webster RG. Disquisitions on original antigenic sin. II. Proof in lower creatures. J Exp Med 1966;124:347-361.
75. Ray CA, et al. Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1β converting enzyme. Cell 1992;69:597-604.
76. Upton C, Mossman K, McFadden G. Encoding of a homolog of the IFN-γ receptor by myxoma virus. Science 1992;258:1369-1372.
77. Brutkiewicz RR, Klaus SJ, Welsh RM. Window of vulnerability of vaccinia virus-infected cells to natural killer cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 Class I antigen expression. Nat Immun 1992;11:203-214.
78. Karupiah G, Xie Q-W, Buller RML, Nathan C, Duarte C, MacMicking JD. Inhibition of viral replication by interferon gamma-induced nitric oxide synthase. Science 1993;261:1445-1448.
79. Haas W, Pereira P, Tonegawa S. Gamma/delta cells. Annu Rev Immunol 1993;11:637-685.
80. Takada H, Matsuzaki G, Hiromatsu K, Nomoto K. Analysis of the role of natural killer cells in Listeria monocytogenes infection: relation between natural killer and T-cell receptor gamma/delta T cells in the host defence mechanism at the early stage of infection. Immunology 1994;82:106-112.
81. Kos FJ, Engleman EG. Immune regulation: a critical link between NK cells and CTLs. Immunol Today 1996;17:174-176.
82. hi T lymphocytes accumulate with age in mice and respond poorly to concanavalin A. Eur J Immunol 1989;19:977-982.
83. Janeway CA. Innate immunity acknowledged. The Immunologist 1995;3:198-200.